Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

A substance called compound-1 could help increase hair growth by maintaining prostaglandin levels in hair follicles.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Crataeva nurvala leaves may help reduce anxiety and improve sleep.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Niosomes improve aminexil's effectiveness in preventing hair loss without needing propylene glycol.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Synthetic hormone treatment reduces melanin and hair growth in rats.

The new treatment using tiny lipid carriers to deliver minoxidil and latanoprost directly to hair follicles shows promise for alopecia.

Sandalore, a synthetic scent, was found to reduce hair loss and improve hair growth in women with hair shedding issues.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

A new minoxidil-like substance, triaminodil, was found in an illegal hair growth supplement.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Nelfb is essential for dermal fat development and survival.

Stopping nalfurafine reversed hair loss in a hemodialysis patient.

Microwave extraction is an effective, eco-friendly way to boost N. jatamansi's anti-Alzheimer's properties.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

A new treatment for hair loss shows promise with fewer side effects.